A study to compare “ipatasertib + chemotherapy” with “placebo + chemotherapy” – in patients with inoperable or metastatic triple negative breast cancer
A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors
Cancer Breast Cancer Breast Neoplasms Tumor
For the latest version of this information please go to www.forpatients.roche.com